state administration of traditional chinese medicine
AstraZeneca Invests US$200m Into Manufacturing Facility In China Medical City
AstraZeneca today announced a US$200 million investment in a new manufacturing facility, located in China Medical City, Taizhou, Jiangsu province in Eastern China.